What We're Reading: COVID-19 Vaccine Mandates; Guidance for Prostate Cancer Trials; Ongoing COVID-19 Variant Threat
Anthony Fauci, MD, addresses potential vaccine mandates once COVID-19 vaccines gain full approval; the FDA issues finalized guidance on using a metastasis-free survival end point in clinical trials of patients with prostate cancer; spotlighting the threat of variant spread and mutation amid case surges nationwide.
Fauci on Vaccine Mandates After Full Approval of COVID-19 Vaccines
As reported by
FDA Issues Guidance on Use of Metastasis-Free Survival End Point
The FDA has issued finalized guidance on the use of metastasis-free survival (MFS) as an end point in clinical trials for patients with nonmetastatic castration-resistant prostate cancer. Reported by
Threat of Variant Spread Continues Amid Surge in Cases
With surges in COVID-19 infections and hospitalizations in states such as
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025